Covering 200+ CDC-priority pathogens | 81 Million+ high-specificity probes
End-to-End workflow from extraction to analysis
Industry-leading microbial capture technology for your research and diagnostics
Covering 200+ pathogens related to human and animal health, including all CDC and WHO priority pathogens
Unlike partial genome detection, we provide true full-length genome capture with estimated coverage exceeding 99%
Rigorously validated through bioinformatics screening and wet-lab experiments to avoid cross-reactivity
Optimized for low-abundance infections, capable of stable capture even with minimal pathogen nucleic acids
Designed based on NCBI multi-strain sequences to effectively capture different variants and emerging mutations
Complete solutions from extraction, library prep, hybridization capture to data analysis with automation options
Meeting all your needs from research exploration to clinical applications
Whole-Genome Pathogen Capture
Targeted NGS Detection
End-to-End Workflow
Lab Automation
From sample to results - a complete turnkey solution
Multiple sample types
Efficient nucleic acid extraction
Enzymatic fragmentation
Fast & efficient construction
Solution-based hybridization
High-specificity enrichment
Platform compatible
Illumina / MGI
Professional pipeline
Visual reporting
Serving public health, scientific research, clinical diagnostics and more
Supporting pathogen detection research for respiratory, gastrointestinal, bloodstream and other infections
Emerging infectious disease monitoring, variant tracking, and epidemiological investigations
Full-genome coverage enables antimicrobial resistance gene discovery for precision medicine research
Covering human and animal pathogens, supporting One Health research initiatives
Pathogen evolution, host-pathogen interactions, integration site analysis and more
CDC-priority pathogen surveillance, biosafety, food safety testing
Multiple high-impact studies have utilized our capture technology
Researchers from Tongji Hospital used our custom liquid hybridization capture technology to reveal the complexity of HPV integration.
Published in BMC GenomicsChongqing Medical University developed an improved DNA probe capture and NGS strategy to detect HBV DNA integration in patient plasma cfDNA.
Published in Virologica SinicaPerformance validation across EBV, Mycoplasma pneumoniae, Vibrio cholerae, Norovirus and many more pathogens.
View More CasesContact us for product details and customized solutions